• Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Consensus Recommendation of "Moderate Buy" from Analysts

    Source: Buzz FX / 03 Dec 2024 02:31:11   America/Chicago


    Celldex Therapeutics, Inc. (NASDAQ:CLDX) Receives Consensus Recommendation of "Moderate Buy" from Analysts Written by MarketBeat December 3, 2024 Share Link copied to clipboard. Celldex Therapeutics, Inc.
    Read more...
Share on,